The effector program of human CD8 T cells supports tissue remodeling.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
05 Feb 2024
Historique:
received: 21 03 2023
revised: 19 10 2023
accepted: 06 12 2023
medline: 16 1 2024
pubmed: 16 1 2024
entrez: 16 1 2024
Statut: ppublish

Résumé

CD8 T lymphocytes are classically viewed as cytotoxic T cells. Whether human CD8 T cells can, in parallel, induce a tissue regeneration program is poorly understood. Here, antigen-specific assay systems revealed that human CD8 T cells not only mediated cytotoxicity but also promoted tissue remodeling. Activated CD8 T cells could produce the epidermal growth factor receptor (EGFR)-ligand amphiregulin (AREG) and sensitize epithelial cells for enhanced regeneration potential. Blocking the EGFR or the effector cytokines IFN-γ and TNF could inhibit tissue remodeling. This regenerative program enhanced tumor spheroid and stem cell-mediated organoid growth. Using single-cell gene expression analysis, we identified an AREG+, tissue-resident CD8 T cell population in skin and adipose tissue from patients undergoing abdominal wall or abdominoplasty surgery. These tissue-resident CD8 T cells showed a strong TCR clonal relation to blood PD1+TIGIT+ CD8 T cells with tissue remodeling abilities. These findings may help to understand the complex CD8 biology in tumors and could become relevant for the design of therapeutic T cell products.

Identifiants

pubmed: 38226976
pii: 276504
doi: 10.1084/jem.20230488
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Research Council
ID : #648145 REGiREG
Pays : International

Informations de copyright

© 2024 Delacher et al.

Auteurs

Michael Delacher (M)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.
Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.

Lisa Schmidleithner (L)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Malte Simon (M)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Faculty of Biosciences, Heidelberg University , Heidelberg, Germany.
Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany.

Philipp Stüve (P)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Lieke Sanderink (L)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Agnes Hotz-Wagenblatt (A)

Core Facility Omics IT and Data Management, German Cancer Research Center , Heidelberg, Germany.

Marina Wuttke (M)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Kathrin Schambeck (K)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Brigitte Ruhland (B)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Veronika Hofmann (V)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Sebastian Bittner (S)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Uwe Ritter (U)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Asmita Pant (A)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Sara Salome Helbich (SS)

Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.

Morten Voss (M)

Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.

Niels A Lemmermann (NA)

Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.
Institute of Virology, University Medical Center Mainz , Mainz, Germany.
Institute of Virology, University of Bonn , Bonn, Germany.

Lisa Bessiri-Schake (L)

Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.

Toszka Bohn (T)

Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.

Andreas Eigenberger (A)

Department of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.

Ayse Nur Menevse (AN)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Interventional Immunology, University Regensburg , Regensburg, Germany.

Claudia Gebhard (C)

Leibniz Institute for Immunotherapy , Regensburg, Germany.

Nicholas Strieder (N)

Leibniz Institute for Immunotherapy , Regensburg, Germany.

Hinrich Abken (H)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Genetic Immunotherapy, University Regensburg , Regensburg, Germany.

Michael Rehli (M)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Jochen Huehn (J)

Department of Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Hannover Medical School , Hannover, Germany.
RESIST, Cluster of Excellence 2155, Hannover Medical School , Hannover, Germany.

Philipp Beckhove (P)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Interventional Immunology, University Regensburg , Regensburg, Germany.
Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Thomas Hehlgans (T)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Henrik Junger (H)

Department of Surgery, University Hospital Regensburg, Regensburg, Germany.

Edward K Geissler (EK)

Department of Surgery, University Hospital Regensburg, Regensburg, Germany.

Lukas Prantl (L)

Department of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.

Jens M Werner (JM)

Department of Surgery, University Hospital Regensburg, Regensburg, Germany.

Christian Schmidl (C)

Leibniz Institute for Immunotherapy , Regensburg, Germany.

Benedikt Brors (B)

Faculty of Biosciences, Heidelberg University , Heidelberg, Germany.
Faculty of Medicine Heidelberg, Heidelberg University , Heidelberg, Germany.
Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
National Center for Tumor Diseases , Heidelberg, Germany.
German Cancer Consortium, German Cancer Research Center , Heidelberg, Germany.

Charles D Imbusch (CD)

Institute of Immunology, University Medical Center Mainz , Mainz, Germany.
Research Center for Immunotherapy, University Medical Center Mainz , Mainz, Germany.
Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany.

Markus Feuerer (M)

Leibniz Institute for Immunotherapy , Regensburg, Germany.
Chair for Immunology, University Regensburg , Regensburg, Germany.

Classifications MeSH